← Back to Search

Behavioral Intervention

Trauma-focused Psychotherapy for PTSD and HIV (TFPP-PLWH Trial)

N/A
Recruiting
Led By Barbara Milrod, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 5, week 12 (treatment termination), 3-month post-treatment follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new psychotherapy to help people living with HIV manage their PTSD, and understand the relationship between HIV and PTSD.

Who is the study for?
This trial is for people living with HIV who also have PTSD. Participants must have a confirmed diagnosis of PTSD with a certain severity score and be on stable psychiatric medication for at least two months, which will continue during the study.
What is being tested?
The trial is testing trauma-focused psychodynamic psychotherapy, a type of therapy that helps patients reflect on emotions and relationships affected by trauma without directly exposing them to traumatic memories.
What are the potential side effects?
Since this is a psychological therapy, side effects may include emotional discomfort or distress as individuals explore difficult experiences and feelings related to their trauma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 5, week 12 (treatment termination), 3-month post-treatment follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 5, week 12 (treatment termination), 3-month post-treatment follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in PTSD Score based on the Clinician Administered PTSD Scale for DSM-5
Secondary study objectives
Attrition from treatment by end of therapy duration
Change in AIDS Clinical Trials Group Adherence Questionnaire
Change in Anxiety Score based on the Hamilton Rating Scale for Anxiety (HAM-A)
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Trauma-focused psychodynamic psychotherapyExperimental Treatment1 Intervention
Twice-weekly psychotherapy for 24 sessions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Trauma-focused psychodynamic psychotherapy
2020
N/A
~20

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
458 Previous Clinical Trials
588,594 Total Patients Enrolled
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,336 Previous Clinical Trials
5,382,814 Total Patients Enrolled
Barbara Milrod, MDPrincipal InvestigatorMontefiore Medical Center
2 Previous Clinical Trials
276 Total Patients Enrolled

Media Library

Trauma-focused psychodynamic psychotherapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05929911 — N/A
Post-Traumatic Stress Disorder Research Study Groups: Trauma-focused psychodynamic psychotherapy
Post-Traumatic Stress Disorder Clinical Trial 2023: Trauma-focused psychodynamic psychotherapy Highlights & Side Effects. Trial Name: NCT05929911 — N/A
Trauma-focused psychodynamic psychotherapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05929911 — N/A
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top